Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

Cell

Volumn 95, Issue 3, 1998, Pages 365-377

  Hiraoka, Nobuaki ^a   Allen, Edward ^a   Apel, Ingrid J ^a   Gyetko, Margaret R ^b   Weiss, Stephen J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; MATRIX METALLOPROTEINASE; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBRINOLYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

EID: 0032582686     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81768-7     Document Type: Article

References (59)

1. Basbaum, C.B., and Werb, Z. (1996). Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell Biol. 8, 731-738.
2. Bini, A., Itoh, Y., Kudryk, B.J., and Nagase, H. (1996). Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the γ Gly 404-Ala 405 peptide bond. Biochemistry 35, 13056-13063.
3. Blobel, C.P. (1997). Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNFα and notch. Cell 90, 589-592.
4. Bode, W., Gomis-Ruth, F.-X., and Stockler, W. (1993). Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett. 331, 134-140.
5. Botos, I., Scapozza, L., Zhang, D., Liotta, L.A., and Meyer, E.F. (1996). Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc. Natl. Acad. Sci. USA 39, 2749-2754.
6. Brooks, P.C., Clark, R.A.F., and Cheresh, D.A. (1994). Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569-571.
7. Brooks, P.C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., Quigley, J.P., and Cheresh, D.A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85, 683-693.
8. Brooks, P.C., Silletti, S., von Schlascha, T.L., and Friedlander, M. (1998). Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400.
9. Brown, L.F., Lanir, N., McDonagh, J., Tognazzi, K., Dvorak, A.M., and Dvorak, H.F. (1993). Fibroblast migration in fibrin gel matrices. Am. J. Pathol. 142, 273-283.
10. Bugge, T.H., Flick, M.J., Daugherty, C.C., and Degen, J.L. (1995). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9, 794-807.
11. Bugge, T.H., Flick, M.J., Danton, M.J.S., Daugherty, C.C., Romer, J., Dano, K., Carmeliet, P., Collen, D., and Degen, J.L. (1996a). Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA 93, 5899-5904.
12. Bugge, T.H., Kombrinck, K.W., Flick, M.J., Daugherty, C.C., Danton, M.J.S., and Degen, J.L. (1996b). Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87, 709-719.
13. Bugge, T.H., Kombrinck, K.W., Xiao, Q., Holmback, K., Daugherty, C.C., Witte, D.P., and Degen, J.L. (1997). Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood 89, 4522-4531.
14. Butler, G.S., Butler, M.J., Atkinson, S.J., Will, H., Tamura, T., van Westrum, S.S., Crabbe, T., Clements, J., d'Ortho, M.-P., and Murphy, G. (1998). The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. J. Biol. Chem. 273, 871-880.
15. Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J.J., Collen, D., and Mulligan, R.C. (1994). Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419-424.
16. Carmeliet, P., Moons, L., Lijnen, R., Baes, M., Lemaitre, V., Tipping, P., Drew, A., Eeckhout, Y., Shapiro, S., Lupu, F., and Collen, D. (1997a). Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17, 439-444.
17. Carmeliet, P., Moons, L., Ploplis, V., Plow, E.F., and Collen, D. (1997b). Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J. Clin. Invest. 99, 200-208.
18. Carmeliet, P., Moons, L., Dewerchin, M., Rosenberg, S., Herbert, J.-M., Lupu, F., and Collen, D. (1998). Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J. Cell Biol. 140, 233-245.
19. Chapman, H.A. (1997). Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9, 714-724.
20. Chen, Z.-L., and Strickland, S. (1997). Neuronal death in the hippo-campus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917-925.
21. Corcoran, M.L., and Stetler-Stevenson, W.G. (1995). Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J. Biol. Chem. 270, 13453-13459.
22. Dvorak, H.F., Harvey, V.S., Estrella, P., Brown, L.F., McDonagh, J., and Dvorak, A.M. (1987). Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Invest. 57, 673-686.
23. Dvorak, H.F., Brown, L.F., Detmar, M., and Dvorak, A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039.
24. Eitzman, D.T., McCoy, R.D., Zheng, X., Fay, W.P., Shen, T., Ginsburg, D., and Simon, R.H. (1996). Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97, 232-237.
25. Folkman, J., and D'Amore, P.A. (1996). Blood vessel formation: what is its molecular basis? Cell 87, 1153-1155.
26. Gailit, J., and Clark, R.A.F. (1994). Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 6, 717-725.
27. Gomis-Ruth, F.-X., Kress, L.F., and Bode, W. (1993). First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/ collagenases. EMBO J. 12, 4151-4157.
28. Hanahan, D. (1997). Signaling vascular morphogenesis and maintenance. Science 277, 48-50.
29. Huber, A.R., Kunkel, S.L., Todd, III, R.T., and Weiss, S.J. (1991). Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254, 99-102.
30. Itoh, T., Ikeda, T., Gomi, H., Nakao, S., Suzuki, T., and Itohara, S. (1997). Unaltered secretion of β-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272, 22389-22392.
31. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., and Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051.
32. Kitching, A.R., Holdsworth, S.R., Ploplis, V.A., Plow, E.F., Collen, D., Carmeliet, P., and Tipping, P.G. (1997). Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J. Exp. Med. 185, 963-968.
33. Koolwijk, P., van Erck, M.G.M., de Vree, W.J.A., Vermeer, M.A., Weich, H.A., Hanemaaijer, R., and van Hinsbergh, V.W.M. (1996). Cooperative effect of TNFα, βFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J. Cell Biol. 132, 1177-1188.
34. Maquoi, E., Noel, A., Frankenne, F., Angliker, H., Murphy, G., and Foidart, J.-M. (1998). Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett. 424, 262-266.
35. Montesano, R., Pepper, M.S., Mohle-Steinlein, U., Risau, W., Wagner, E.F., and Orel, L. (1990). Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62, 435-445.
36. Mudgett, J.S., Hutchinson, N.I., Chartrain, N.A., Forsyth, A.J., McDonnell, J., Singer, I.I., Bayne, E.K., Flanagan, J., Kawka, D., Shen, C.F., et al. (1998). Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum. 41, 110-121.
37. Nakahara, H., Howard, L., Thompson, E.W., Sato, H., Seiki, M., Yeh, Y., and Chen, W.-T. (1997). Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA 94, 7959-7964.
38. Nicosia, R.F., and Tuszynski, G.P. (1994). Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol. 124, 183-193.
39. Nomura, H., Sato, H., Seiki, M., Mai, M., and Okada, Y. (1995). Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 55, 3263-3266.
40. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. (1997). Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272, 2446-2451.
41. Okada, A., Tomasetto, C., Lutz, Y., Bellocq, J.-P., Rio, M.-C., and Basset, P. (1997). Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J. Cell Biol. 137, 67-77.
42. Pei, D., and Weiss, S.J. (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244-247.
43. Pei, D., and Weiss, S.J. (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271, 9135-9140.
44. Pei, D., Majmudar, G., and Weiss, S.J. (1994). Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269, 25849-25855.
45. Pepper, J.S., Montesano, R., Mandriota, S.J., Orel, L., and Vassalli, J.-D. (1996). Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138-162.
46. Pilcher, B.K., Dumin, J.A., Sudbeck, B.D., Krane, S.M., Welgus, H.G., and Parks, W.C. (1997). The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137, 1445-1457.
47. Ploplis, V., Carmeliet, P., Vazirzadeh, S., Van Vlaenderen, I., Moons, L., Plow, E., and Collen, D. (1995). Effects of disruption of the plasminogen gene on thrombosis, growth and health in mice. Circulation 92, 2582-2593.
48. Reddy, V.Y., Zhang, Q.-Y., and Weiss, S.J. (1995). Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 92, 3849-3853.
49. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
50. Romer, J., Bugge, T.H., Pyke, C., Lund, LR., Flick, M.J., Degen, J.L., and Dano, K. (1996). Impaired wound healing in mice with a disrupted plasminogen gene. Nat. Med. 2, 287-292.
51. Sabapathy, K.T., Pepper, M.S., Kiefer, F., Mohle-Steinlein, U., Tacchini-Cottier, F., Fetka, I., Breier, G., Risau, W., Carmeliet, P., Montesano, R., and Wagner, E.F. (1997). Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/ plasmin system. J. Cell Biol. 137, 953-963.
52. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-64.
53. Schuster, B., Mingers, A.-M., Seidenspinner, S., Nussgens, Z., Pukrop, T., and Kreth, H.W. (1997). Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. Blood 90, 958-966.
54. Senger, D.R. (1996). Molecular framework for angiogenesis. Am. J. Pathol. 749, 1-7.
55. Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M., and Okada, Y. (1997). Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57, 2055-2060.
56. Werb, Z. (1997). ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91, 439-442.
57. Xiao, Q., Danton, M.J. S., Witte, D.P., Kowala, M.C., Valentine, M.T., Bugge, T.H., and Degen, J.L. (1997). Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. Proc. Natl. Acad. Sci. USA 94, 10335-10340.
58. Yebra, M., Parry, G.C.N., Stromblad, S., Mackman, N., Rosenberg, S., Mueller, B.M., and Cheresh, D.A. (1996). Requirement of receptor-bound urokinase-type plasminogen activator for integrin avb5-directed cell migration. J. Biol. Chem. 271, 29393-29399.
59. Zucker, S., Conner, C., DiMassmo, B.I., Ende, H., Drews, M., Seiki, M., and Bahou, W.F. (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J. Biol. Chem. 270, 23730-23738.